Urologic oncology randomized controlled trials are frequently fragile - A review of the urology literature

CONCLUSIONS: Randomized controlled trials in urology journals that study dichotomous outcomes often report fragile results that should be regarded with caution. Reporting the FI alongside P values may enhance the interpretation and implementation of urologic oncology RCT's.PMID:34103225 | DOI:10.1016/j.urolonc.2021.04.037
Source: Urologic Oncology - Category: Urology & Nephrology Authors: Source Type: research